FDA panel endorses lower-dose Moderna COVID-19 shot for booster
The Hindu
The recommendation is non-binding but it’s a key step toward expanding the U.S. booster campaign to millions more Americans.
U.S. health advisers said on October 14 that some Americans who received Moderna’s COVID-19 vaccine should get a half-dose booster to bolster protection against the virus.
The panel of advisers to the Food and Drug Administration voted unanimously to recommend a booster shot for seniors, adults with other health problems, jobs or living situations that put them at increased risk for COVID-19.
The recommendation is non-binding but it’s a key step toward expanding the U.S. booster campaign to millions more Americans. Many people who got their initial Pfizer shots at least six months ago are already getting a booster after the FDA authorised their use in September.